In the current study, we investigated the correlations of intratumoral GM-CSF expression with clinicopathologic characteristics and prognosis of 233 clinically localized ccRCC patients after surgical treatment. The gene discussed is CSF2; the disease is nonpapillary renal cell carcinoma.